Aprepitant, the first NK-1 receptor antagonist available for the treatment of chemotherapy-induced nausea and vomiting

Research output: Contribution to journalArticleAcademic

Original languageUndefined/Unknown
Pages (from-to)391-413
Number of pages23
JournalToday's Therapeutic Trends
Volume21
Issue number4
Publication statusPublished - 2003

Research programs

  • EMC MM-03-86-08
  • EMC OR-01-86-13

Cite this